Login
Related Links
Gene Therapy Research Institutes - Australia
- Cell and Molecular Therapies, Royal Prince Alfred Hospital, Camperdown
- Centenary Institute of Cancer Medicine and Cell Biology, Sydney
- Gene Silencing and Expression Facility (GSEx), Adelaide
- Gene Therapy Research Unit, Children's Medical Research Unit
HPC-A collection, processing, storage and transplant cGMP manufacturing of cell and gene modified human cells for clinical use.
Research is focussed on a combination of cancer, cell biology, molecular medicine and immunology. Research includes retroviral receptors, AAV gene transfer, novel retrovirus packaging cell lines, hemopoietic and mesenchymal stem cells.
The Gene Silencing and Expression (GSEx) facility is a non-profit service lab providing viral vectors and other molecular services to researchers internal and external to the University of Adelaide.
Research is focused on liver-targeted gene therapy, nerve and muscle diseases, Cystic Fibrosis and gene therapy for the prevention of malaria.
Info Research Centers
Overview of research institutes, centers and universities involved in pre-clinical and clinical gene therapy research:
Check here also the European Union Framework Programme Six (FP6) Integrated Projects, such as Attack, Clinigene, Consert and GIANT.
See also the European Union Framework Programme Seven (FP7) Integrated Projects.
Your Research Institute not listed? Click here to suggest
Like to work for a research center? Find here the perfect job in gene therapy.
 |
US & Canada |
|
Europe |
|
Australia |
Check here also the European Union Framework Programme Six (FP6) Integrated Projects, such as Attack, Clinigene, Consert and GIANT.
See also the European Union Framework Programme Seven (FP7) Integrated Projects.
Your Research Institute not listed? Click here to suggest
Like to work for a research center? Find here the perfect job in gene therapy.
Gene Therapy News
- Genethon’s Gene Therapy GNT0004 Continues to Show Potential in DMD - CGTLive™
Wed, 19 Mar 2025 23:56:5 GMT - Sarepta’s gene therapy faced internal FDA doubts. Now, a teen has died - Healthcare Brew
Wed, 19 Mar 2025 23:02:1 GMT - Gene Therapy Tested in Mice Offers New Hope for People with Dravet Syndrome - Genetic Engineering & Biotechnology News
Wed, 19 Mar 2025 22:25:1 GMT - Around the Helix: Cell and Gene Therapy Company Updates – March 19, 2025 - CGTLive™
Wed, 19 Mar 2025 22:22:3 GMT - Breakthrough gene therapy alleviates Dravet syndrome symptoms in mice without side effects - Medical Xpress
Wed, 19 Mar 2025 21:36:0 GMT - STEER Data Open Door to SMA Gene Therapy for Wider Age Range of Children - AJMC.com Managed Markets Network
Wed, 19 Mar 2025 21:06:2 GMT - Novartis reports positive Phase III results for SMA gene therapy OAV101 IT - The Pharma Letter
Wed, 19 Mar 2025 20:16:0 GMT - Novartis New Data From Single-Dose Gene Therapy Shows Meaningful Efficacy, Safety In Patients With Spinal Muscular Atrophy - AOL
Wed, 19 Mar 2025 20:09:2 GMT - Regenxbio touts biomarker data for DMD gene therapy, but safety could be its winning argument - FirstWord Pharma
Wed, 19 Mar 2025 19:58:5 GMT - Gene Therapy Offers Hope for Dravet Syndrome Treatment - Technology Networks
Wed, 19 Mar 2025 19:04:2 GMT - Therapeutic potential of AAV2-shmTOR gene therapy in reducing retinal inflammation and preserving endothelial Integrity in age-related macular degeneration - Nature.com
Wed, 19 Mar 2025 18:16:2 GMT - Sarepta's gene therapy under scrutiny after patient death - Medical Xpress
Wed, 19 Mar 2025 18:00:0 GMT - Regenxbio Touts Positive Biomarker Data From Duchenne Muscular Dystrophy Gene Therapy Trial - Benzinga
Wed, 19 Mar 2025 17:38:5 GMT - Benitec Biopharma’s SWOT analysis: gene therapy stock shows promise in OPMD - Investing.com UK
Wed, 19 Mar 2025 17:08:0 GMT - Regenxbio shares new Duchenne gene therapy data ahead of big readout next year - Endpoints News
Wed, 19 Mar 2025 16:14:0 GMT